nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—CYP1A1—Omeprazole—Barrett's esophagus	0.157	0.22	CbGbCtD
Fluvoxamine—CYP2C19—Esomeprazole—Barrett's esophagus	0.129	0.181	CbGbCtD
Fluvoxamine—CYP2C19—Omeprazole—Barrett's esophagus	0.0759	0.107	CbGbCtD
Fluvoxamine—CYP1A2—Omeprazole—Barrett's esophagus	0.07	0.0983	CbGbCtD
Fluvoxamine—CYP2C9—Omeprazole—Barrett's esophagus	0.0631	0.0885	CbGbCtD
Fluvoxamine—CYP3A4—Esomeprazole—Barrett's esophagus	0.0623	0.0874	CbGbCtD
Fluvoxamine—ABCB1—Omeprazole—Barrett's esophagus	0.0612	0.0859	CbGbCtD
Fluvoxamine—CYP2D6—Omeprazole—Barrett's esophagus	0.0577	0.081	CbGbCtD
Fluvoxamine—CYP3A4—Omeprazole—Barrett's esophagus	0.0367	0.0515	CbGbCtD
Fluvoxamine—Gastroenteritis—Omeprazole—Barrett's esophagus	0.000934	0.00356	CcSEcCtD
Fluvoxamine—Gastroenteritis—Esomeprazole—Barrett's esophagus	0.000934	0.00356	CcSEcCtD
Fluvoxamine—Vascular purpura—Omeprazole—Barrett's esophagus	0.000926	0.00352	CcSEcCtD
Fluvoxamine—Vascular purpura—Esomeprazole—Barrett's esophagus	0.000926	0.00352	CcSEcCtD
Fluvoxamine—Injury—Esomeprazole—Barrett's esophagus	0.000901	0.00343	CcSEcCtD
Fluvoxamine—Injury—Omeprazole—Barrett's esophagus	0.000901	0.00343	CcSEcCtD
Fluvoxamine—Increased appetite—Esomeprazole—Barrett's esophagus	0.000881	0.00335	CcSEcCtD
Fluvoxamine—Increased appetite—Omeprazole—Barrett's esophagus	0.000881	0.00335	CcSEcCtD
Fluvoxamine—Visual disturbance—Esomeprazole—Barrett's esophagus	0.000874	0.00333	CcSEcCtD
Fluvoxamine—Visual disturbance—Omeprazole—Barrett's esophagus	0.000874	0.00333	CcSEcCtD
Fluvoxamine—Thirst—Omeprazole—Barrett's esophagus	0.00087	0.00331	CcSEcCtD
Fluvoxamine—Renal impairment—Omeprazole—Barrett's esophagus	0.00087	0.00331	CcSEcCtD
Fluvoxamine—Thirst—Esomeprazole—Barrett's esophagus	0.00087	0.00331	CcSEcCtD
Fluvoxamine—Renal impairment—Esomeprazole—Barrett's esophagus	0.00087	0.00331	CcSEcCtD
Fluvoxamine—Purpura—Esomeprazole—Barrett's esophagus	0.000859	0.00327	CcSEcCtD
Fluvoxamine—Purpura—Omeprazole—Barrett's esophagus	0.000859	0.00327	CcSEcCtD
Fluvoxamine—Arthritis—Esomeprazole—Barrett's esophagus	0.000852	0.00324	CcSEcCtD
Fluvoxamine—Arthritis—Omeprazole—Barrett's esophagus	0.000852	0.00324	CcSEcCtD
Fluvoxamine—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.000849	0.00323	CcSEcCtD
Fluvoxamine—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.000849	0.00323	CcSEcCtD
Fluvoxamine—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.000831	0.00316	CcSEcCtD
Fluvoxamine—Hyponatraemia—Omeprazole—Barrett's esophagus	0.000831	0.00316	CcSEcCtD
Fluvoxamine—Osteoarthritis—Esomeprazole—Barrett's esophagus	0.000828	0.00315	CcSEcCtD
Fluvoxamine—Diplopia—Omeprazole—Barrett's esophagus	0.000828	0.00315	CcSEcCtD
Fluvoxamine—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.000828	0.00315	CcSEcCtD
Fluvoxamine—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.000828	0.00315	CcSEcCtD
Fluvoxamine—Osteoarthritis—Omeprazole—Barrett's esophagus	0.000828	0.00315	CcSEcCtD
Fluvoxamine—Diplopia—Esomeprazole—Barrett's esophagus	0.000828	0.00315	CcSEcCtD
Fluvoxamine—Migraine—Esomeprazole—Barrett's esophagus	0.000815	0.0031	CcSEcCtD
Fluvoxamine—Migraine—Omeprazole—Barrett's esophagus	0.000815	0.0031	CcSEcCtD
Fluvoxamine—Face oedema—Omeprazole—Barrett's esophagus	0.000799	0.00304	CcSEcCtD
Fluvoxamine—Face oedema—Esomeprazole—Barrett's esophagus	0.000799	0.00304	CcSEcCtD
Fluvoxamine—Irritability—Omeprazole—Barrett's esophagus	0.00079	0.00301	CcSEcCtD
Fluvoxamine—Irritability—Esomeprazole—Barrett's esophagus	0.00079	0.00301	CcSEcCtD
Fluvoxamine—Dry skin—Omeprazole—Barrett's esophagus	0.000759	0.00289	CcSEcCtD
Fluvoxamine—Dry skin—Esomeprazole—Barrett's esophagus	0.000759	0.00289	CcSEcCtD
Fluvoxamine—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.000754	0.00287	CcSEcCtD
Fluvoxamine—Hypokalaemia—Omeprazole—Barrett's esophagus	0.000754	0.00287	CcSEcCtD
Fluvoxamine—Breast disorder—Omeprazole—Barrett's esophagus	0.000748	0.00285	CcSEcCtD
Fluvoxamine—Breast disorder—Esomeprazole—Barrett's esophagus	0.000748	0.00285	CcSEcCtD
Fluvoxamine—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.000746	0.00284	CcSEcCtD
Fluvoxamine—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.000746	0.00284	CcSEcCtD
Fluvoxamine—Gastritis—Esomeprazole—Barrett's esophagus	0.000733	0.00279	CcSEcCtD
Fluvoxamine—Gastritis—Omeprazole—Barrett's esophagus	0.000733	0.00279	CcSEcCtD
Fluvoxamine—Muscular weakness—Omeprazole—Barrett's esophagus	0.00073	0.00278	CcSEcCtD
Fluvoxamine—Muscular weakness—Esomeprazole—Barrett's esophagus	0.00073	0.00278	CcSEcCtD
Fluvoxamine—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000726	0.0295	CbGpPWpGaD
Fluvoxamine—Abdominal distension—Omeprazole—Barrett's esophagus	0.000721	0.00274	CcSEcCtD
Fluvoxamine—Abdominal distension—Esomeprazole—Barrett's esophagus	0.000721	0.00274	CcSEcCtD
Fluvoxamine—Asthma—Omeprazole—Barrett's esophagus	0.000716	0.00272	CcSEcCtD
Fluvoxamine—Dysphagia—Esomeprazole—Barrett's esophagus	0.000716	0.00272	CcSEcCtD
Fluvoxamine—Dysphagia—Omeprazole—Barrett's esophagus	0.000716	0.00272	CcSEcCtD
Fluvoxamine—Influenza—Omeprazole—Barrett's esophagus	0.000716	0.00272	CcSEcCtD
Fluvoxamine—Influenza—Esomeprazole—Barrett's esophagus	0.000716	0.00272	CcSEcCtD
Fluvoxamine—Asthma—Esomeprazole—Barrett's esophagus	0.000716	0.00272	CcSEcCtD
Fluvoxamine—Pancreatitis—Esomeprazole—Barrett's esophagus	0.000702	0.00267	CcSEcCtD
Fluvoxamine—Pancreatitis—Omeprazole—Barrett's esophagus	0.000702	0.00267	CcSEcCtD
Fluvoxamine—Sweating increased—Esomeprazole—Barrett's esophagus	0.000697	0.00265	CcSEcCtD
Fluvoxamine—Sweating increased—Omeprazole—Barrett's esophagus	0.000697	0.00265	CcSEcCtD
Fluvoxamine—Angina pectoris—Omeprazole—Barrett's esophagus	0.000697	0.00265	CcSEcCtD
Fluvoxamine—Angina pectoris—Esomeprazole—Barrett's esophagus	0.000697	0.00265	CcSEcCtD
Fluvoxamine—Dysuria—Esomeprazole—Barrett's esophagus	0.000669	0.00255	CcSEcCtD
Fluvoxamine—Dysuria—Omeprazole—Barrett's esophagus	0.000669	0.00255	CcSEcCtD
Fluvoxamine—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.000665	0.00253	CcSEcCtD
Fluvoxamine—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.000665	0.00253	CcSEcCtD
Fluvoxamine—Pollakiuria—Esomeprazole—Barrett's esophagus	0.000661	0.00252	CcSEcCtD
Fluvoxamine—Pollakiuria—Omeprazole—Barrett's esophagus	0.000661	0.00252	CcSEcCtD
Fluvoxamine—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.000659	0.00251	CcSEcCtD
Fluvoxamine—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.000659	0.00251	CcSEcCtD
Fluvoxamine—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.000653	0.00249	CcSEcCtD
Fluvoxamine—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.000653	0.00249	CcSEcCtD
Fluvoxamine—Weight increased—Esomeprazole—Barrett's esophagus	0.000651	0.00248	CcSEcCtD
Fluvoxamine—Weight increased—Omeprazole—Barrett's esophagus	0.000651	0.00248	CcSEcCtD
Fluvoxamine—Weight decreased—Omeprazole—Barrett's esophagus	0.000648	0.00246	CcSEcCtD
Fluvoxamine—Weight decreased—Esomeprazole—Barrett's esophagus	0.000648	0.00246	CcSEcCtD
Fluvoxamine—Depression—Omeprazole—Barrett's esophagus	0.000636	0.00242	CcSEcCtD
Fluvoxamine—Depression—Esomeprazole—Barrett's esophagus	0.000636	0.00242	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.000633	0.00241	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.000633	0.00241	CcSEcCtD
Fluvoxamine—Renal failure—Esomeprazole—Barrett's esophagus	0.000627	0.00239	CcSEcCtD
Fluvoxamine—Renal failure—Omeprazole—Barrett's esophagus	0.000627	0.00239	CcSEcCtD
Fluvoxamine—Jaundice—Esomeprazole—Barrett's esophagus	0.000622	0.00237	CcSEcCtD
Fluvoxamine—Stomatitis—Esomeprazole—Barrett's esophagus	0.000622	0.00237	CcSEcCtD
Fluvoxamine—Stomatitis—Omeprazole—Barrett's esophagus	0.000622	0.00237	CcSEcCtD
Fluvoxamine—Jaundice—Omeprazole—Barrett's esophagus	0.000622	0.00237	CcSEcCtD
Fluvoxamine—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.00062	0.00236	CcSEcCtD
Fluvoxamine—Conjunctivitis—Omeprazole—Barrett's esophagus	0.00062	0.00236	CcSEcCtD
Fluvoxamine—Urinary tract infection—Omeprazole—Barrett's esophagus	0.00062	0.00236	CcSEcCtD
Fluvoxamine—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.00062	0.00236	CcSEcCtD
Fluvoxamine—Haematuria—Omeprazole—Barrett's esophagus	0.000608	0.00232	CcSEcCtD
Fluvoxamine—Haematuria—Esomeprazole—Barrett's esophagus	0.000608	0.00232	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.000604	0.0023	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.000604	0.0023	CcSEcCtD
Fluvoxamine—Epistaxis—Esomeprazole—Barrett's esophagus	0.000602	0.00229	CcSEcCtD
Fluvoxamine—Epistaxis—Omeprazole—Barrett's esophagus	0.000602	0.00229	CcSEcCtD
Fluvoxamine—Sinusitis—Omeprazole—Barrett's esophagus	0.000599	0.00228	CcSEcCtD
Fluvoxamine—Sinusitis—Esomeprazole—Barrett's esophagus	0.000599	0.00228	CcSEcCtD
Fluvoxamine—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.000596	0.00227	CcSEcCtD
Fluvoxamine—Agranulocytosis—Omeprazole—Barrett's esophagus	0.000596	0.00227	CcSEcCtD
Fluvoxamine—Bradycardia—Esomeprazole—Barrett's esophagus	0.000583	0.00222	CcSEcCtD
Fluvoxamine—Bradycardia—Omeprazole—Barrett's esophagus	0.000583	0.00222	CcSEcCtD
Fluvoxamine—Rhinitis—Esomeprazole—Barrett's esophagus	0.000574	0.00219	CcSEcCtD
Fluvoxamine—Rhinitis—Omeprazole—Barrett's esophagus	0.000574	0.00219	CcSEcCtD
Fluvoxamine—Hepatitis—Esomeprazole—Barrett's esophagus	0.000573	0.00218	CcSEcCtD
Fluvoxamine—Hepatitis—Omeprazole—Barrett's esophagus	0.000573	0.00218	CcSEcCtD
Fluvoxamine—Hallucination—Omeprazole—Barrett's esophagus	0.00057	0.00217	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.00057	0.00217	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.00057	0.00217	CcSEcCtD
Fluvoxamine—Hallucination—Esomeprazole—Barrett's esophagus	0.00057	0.00217	CcSEcCtD
Fluvoxamine—Pharyngitis—Esomeprazole—Barrett's esophagus	0.000569	0.00216	CcSEcCtD
Fluvoxamine—Pharyngitis—Omeprazole—Barrett's esophagus	0.000569	0.00216	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.000566	0.00215	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.000566	0.00215	CcSEcCtD
Fluvoxamine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000565	0.023	CbGpPWpGaD
Fluvoxamine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000565	0.023	CbGpPWpGaD
Fluvoxamine—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.000564	0.00215	CcSEcCtD
Fluvoxamine—Oedema peripheral—Omeprazole—Barrett's esophagus	0.000564	0.00215	CcSEcCtD
Fluvoxamine—Urethral disorder—Omeprazole—Barrett's esophagus	0.000562	0.00214	CcSEcCtD
Fluvoxamine—Urethral disorder—Esomeprazole—Barrett's esophagus	0.000562	0.00214	CcSEcCtD
Fluvoxamine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000554	0.0225	CbGpPWpGaD
Fluvoxamine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000554	0.0225	CbGpPWpGaD
Fluvoxamine—Visual impairment—Esomeprazole—Barrett's esophagus	0.000552	0.0021	CcSEcCtD
Fluvoxamine—Visual impairment—Omeprazole—Barrett's esophagus	0.000552	0.0021	CcSEcCtD
Fluvoxamine—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.000542	0.00206	CcSEcCtD
Fluvoxamine—Erythema multiforme—Omeprazole—Barrett's esophagus	0.000542	0.00206	CcSEcCtD
Fluvoxamine—Eye disorder—Esomeprazole—Barrett's esophagus	0.000535	0.00204	CcSEcCtD
Fluvoxamine—Eye disorder—Omeprazole—Barrett's esophagus	0.000535	0.00204	CcSEcCtD
Fluvoxamine—Tinnitus—Esomeprazole—Barrett's esophagus	0.000534	0.00203	CcSEcCtD
Fluvoxamine—Tinnitus—Omeprazole—Barrett's esophagus	0.000534	0.00203	CcSEcCtD
Fluvoxamine—Chills—Omeprazole—Barrett's esophagus	0.000514	0.00196	CcSEcCtD
Fluvoxamine—Chills—Esomeprazole—Barrett's esophagus	0.000514	0.00196	CcSEcCtD
Fluvoxamine—Alopecia—Esomeprazole—Barrett's esophagus	0.000506	0.00193	CcSEcCtD
Fluvoxamine—Alopecia—Omeprazole—Barrett's esophagus	0.000506	0.00193	CcSEcCtD
Fluvoxamine—CYP1A1—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000506	0.0206	CbGpPWpGaD
Fluvoxamine—Mental disorder—Esomeprazole—Barrett's esophagus	0.000502	0.00191	CcSEcCtD
Fluvoxamine—Mental disorder—Omeprazole—Barrett's esophagus	0.000502	0.00191	CcSEcCtD
Fluvoxamine—Malnutrition—Omeprazole—Barrett's esophagus	0.000499	0.0019	CcSEcCtD
Fluvoxamine—Malnutrition—Esomeprazole—Barrett's esophagus	0.000499	0.0019	CcSEcCtD
Fluvoxamine—Flatulence—Esomeprazole—Barrett's esophagus	0.000491	0.00187	CcSEcCtD
Fluvoxamine—Flatulence—Omeprazole—Barrett's esophagus	0.000491	0.00187	CcSEcCtD
Fluvoxamine—Tension—Esomeprazole—Barrett's esophagus	0.000489	0.00186	CcSEcCtD
Fluvoxamine—Tension—Omeprazole—Barrett's esophagus	0.000489	0.00186	CcSEcCtD
Fluvoxamine—Dysgeusia—Omeprazole—Barrett's esophagus	0.000488	0.00186	CcSEcCtD
Fluvoxamine—Dysgeusia—Esomeprazole—Barrett's esophagus	0.000488	0.00186	CcSEcCtD
Fluvoxamine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000485	0.0197	CbGpPWpGaD
Fluvoxamine—Nervousness—Esomeprazole—Barrett's esophagus	0.000484	0.00184	CcSEcCtD
Fluvoxamine—Nervousness—Omeprazole—Barrett's esophagus	0.000484	0.00184	CcSEcCtD
Fluvoxamine—Back pain—Esomeprazole—Barrett's esophagus	0.000482	0.00184	CcSEcCtD
Fluvoxamine—Back pain—Omeprazole—Barrett's esophagus	0.000482	0.00184	CcSEcCtD
Fluvoxamine—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000479	0.00182	CcSEcCtD
Fluvoxamine—Muscle spasms—Omeprazole—Barrett's esophagus	0.000479	0.00182	CcSEcCtD
Fluvoxamine—CYP3A7—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000479	0.0195	CbGpPWpGaD
Fluvoxamine—Vision blurred—Omeprazole—Barrett's esophagus	0.00047	0.00179	CcSEcCtD
Fluvoxamine—Vision blurred—Esomeprazole—Barrett's esophagus	0.00047	0.00179	CcSEcCtD
Fluvoxamine—Tremor—Omeprazole—Barrett's esophagus	0.000467	0.00178	CcSEcCtD
Fluvoxamine—Tremor—Esomeprazole—Barrett's esophagus	0.000467	0.00178	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000463	0.00176	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000463	0.00176	CcSEcCtD
Fluvoxamine—Anaemia—Omeprazole—Barrett's esophagus	0.000461	0.00175	CcSEcCtD
Fluvoxamine—Anaemia—Esomeprazole—Barrett's esophagus	0.000461	0.00175	CcSEcCtD
Fluvoxamine—CYP2E1—Vitamin A and Carotenoid Metabolism—CYP26A1—Barrett's esophagus	0.000459	0.0187	CbGpPWpGaD
Fluvoxamine—Agitation—Omeprazole—Barrett's esophagus	0.000458	0.00174	CcSEcCtD
Fluvoxamine—Agitation—Esomeprazole—Barrett's esophagus	0.000458	0.00174	CcSEcCtD
Fluvoxamine—Angioedema—Esomeprazole—Barrett's esophagus	0.000456	0.00173	CcSEcCtD
Fluvoxamine—Angioedema—Omeprazole—Barrett's esophagus	0.000456	0.00173	CcSEcCtD
Fluvoxamine—Malaise—Omeprazole—Barrett's esophagus	0.00045	0.00171	CcSEcCtD
Fluvoxamine—Malaise—Esomeprazole—Barrett's esophagus	0.00045	0.00171	CcSEcCtD
Fluvoxamine—Vertigo—Esomeprazole—Barrett's esophagus	0.000448	0.00171	CcSEcCtD
Fluvoxamine—Vertigo—Omeprazole—Barrett's esophagus	0.000448	0.00171	CcSEcCtD
Fluvoxamine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000447	0.0182	CbGpPWpGaD
Fluvoxamine—Leukopenia—Omeprazole—Barrett's esophagus	0.000446	0.0017	CcSEcCtD
Fluvoxamine—Leukopenia—Esomeprazole—Barrett's esophagus	0.000446	0.0017	CcSEcCtD
Fluvoxamine—Palpitations—Omeprazole—Barrett's esophagus	0.000441	0.00168	CcSEcCtD
Fluvoxamine—Palpitations—Esomeprazole—Barrett's esophagus	0.000441	0.00168	CcSEcCtD
Fluvoxamine—Cough—Esomeprazole—Barrett's esophagus	0.000435	0.00166	CcSEcCtD
Fluvoxamine—Cough—Omeprazole—Barrett's esophagus	0.000435	0.00166	CcSEcCtD
Fluvoxamine—Hypertension—Omeprazole—Barrett's esophagus	0.000431	0.00164	CcSEcCtD
Fluvoxamine—Hypertension—Esomeprazole—Barrett's esophagus	0.000431	0.00164	CcSEcCtD
Fluvoxamine—Myalgia—Omeprazole—Barrett's esophagus	0.000425	0.00162	CcSEcCtD
Fluvoxamine—Arthralgia—Esomeprazole—Barrett's esophagus	0.000425	0.00162	CcSEcCtD
Fluvoxamine—Arthralgia—Omeprazole—Barrett's esophagus	0.000425	0.00162	CcSEcCtD
Fluvoxamine—Chest pain—Esomeprazole—Barrett's esophagus	0.000425	0.00162	CcSEcCtD
Fluvoxamine—Myalgia—Esomeprazole—Barrett's esophagus	0.000425	0.00162	CcSEcCtD
Fluvoxamine—Chest pain—Omeprazole—Barrett's esophagus	0.000425	0.00162	CcSEcCtD
Fluvoxamine—Anxiety—Omeprazole—Barrett's esophagus	0.000423	0.00161	CcSEcCtD
Fluvoxamine—Anxiety—Esomeprazole—Barrett's esophagus	0.000423	0.00161	CcSEcCtD
Fluvoxamine—Discomfort—Omeprazole—Barrett's esophagus	0.000419	0.0016	CcSEcCtD
Fluvoxamine—Discomfort—Esomeprazole—Barrett's esophagus	0.000419	0.0016	CcSEcCtD
Fluvoxamine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000417	0.0169	CbGpPWpGaD
Fluvoxamine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000417	0.0169	CbGpPWpGaD
Fluvoxamine—Dry mouth—Omeprazole—Barrett's esophagus	0.000415	0.00158	CcSEcCtD
Fluvoxamine—Dry mouth—Esomeprazole—Barrett's esophagus	0.000415	0.00158	CcSEcCtD
Fluvoxamine—CYP2C19—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000414	0.0168	CbGpPWpGaD
Fluvoxamine—Confusional state—Omeprazole—Barrett's esophagus	0.00041	0.00156	CcSEcCtD
Fluvoxamine—Confusional state—Esomeprazole—Barrett's esophagus	0.00041	0.00156	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.000407	0.00155	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.000407	0.00155	CcSEcCtD
Fluvoxamine—Infection—Omeprazole—Barrett's esophagus	0.000404	0.00154	CcSEcCtD
Fluvoxamine—Infection—Esomeprazole—Barrett's esophagus	0.000404	0.00154	CcSEcCtD
Fluvoxamine—Shock—Omeprazole—Barrett's esophagus	0.0004	0.00152	CcSEcCtD
Fluvoxamine—Shock—Esomeprazole—Barrett's esophagus	0.0004	0.00152	CcSEcCtD
Fluvoxamine—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000399	0.00152	CcSEcCtD
Fluvoxamine—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000399	0.00152	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000399	0.00152	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000399	0.00152	CcSEcCtD
Fluvoxamine—Tachycardia—Omeprazole—Barrett's esophagus	0.000397	0.00151	CcSEcCtD
Fluvoxamine—Tachycardia—Esomeprazole—Barrett's esophagus	0.000397	0.00151	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000393	0.0015	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000393	0.0015	CcSEcCtD
Fluvoxamine—CYP3A7—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000393	0.016	CbGpPWpGaD
Fluvoxamine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00039	0.0158	CbGpPWpGaD
Fluvoxamine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00039	0.0158	CbGpPWpGaD
Fluvoxamine—Anorexia—Omeprazole—Barrett's esophagus	0.000388	0.00148	CcSEcCtD
Fluvoxamine—Anorexia—Esomeprazole—Barrett's esophagus	0.000388	0.00148	CcSEcCtD
Fluvoxamine—SLC6A4—Circadian rythm related genes—CRTC1—Barrett's esophagus	0.000383	0.0156	CbGpPWpGaD
Fluvoxamine—CYP3A5—Irinotecan Pathway—APC—Barrett's esophagus	0.000383	0.0156	CbGpPWpGaD
Fluvoxamine—CYP2C9—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000378	0.0153	CbGpPWpGaD
Fluvoxamine—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000371	0.00141	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000371	0.00141	CcSEcCtD
Fluvoxamine—Insomnia—Esomeprazole—Barrett's esophagus	0.000368	0.0014	CcSEcCtD
Fluvoxamine—Insomnia—Omeprazole—Barrett's esophagus	0.000368	0.0014	CcSEcCtD
Fluvoxamine—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000365	0.00139	CcSEcCtD
Fluvoxamine—Paraesthesia—Omeprazole—Barrett's esophagus	0.000365	0.00139	CcSEcCtD
Fluvoxamine—Dyspnoea—Omeprazole—Barrett's esophagus	0.000363	0.00138	CcSEcCtD
Fluvoxamine—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000363	0.00138	CcSEcCtD
Fluvoxamine—Somnolence—Omeprazole—Barrett's esophagus	0.000362	0.00138	CcSEcCtD
Fluvoxamine—Somnolence—Esomeprazole—Barrett's esophagus	0.000362	0.00138	CcSEcCtD
Fluvoxamine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000359	0.0146	CbGpPWpGaD
Fluvoxamine—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000358	0.00136	CcSEcCtD
Fluvoxamine—Dyspepsia—Omeprazole—Barrett's esophagus	0.000358	0.00136	CcSEcCtD
Fluvoxamine—CYP2B6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000354	0.0144	CbGpPWpGaD
Fluvoxamine—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000354	0.00135	CcSEcCtD
Fluvoxamine—Decreased appetite—Omeprazole—Barrett's esophagus	0.000354	0.00135	CcSEcCtD
Fluvoxamine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000352	0.0143	CbGpPWpGaD
Fluvoxamine—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000351	0.00134	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000351	0.00134	CcSEcCtD
Fluvoxamine—Fatigue—Omeprazole—Barrett's esophagus	0.000351	0.00134	CcSEcCtD
Fluvoxamine—Fatigue—Esomeprazole—Barrett's esophagus	0.000351	0.00134	CcSEcCtD
Fluvoxamine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000351	0.0143	CbGpPWpGaD
Fluvoxamine—Pain—Omeprazole—Barrett's esophagus	0.000348	0.00132	CcSEcCtD
Fluvoxamine—Pain—Esomeprazole—Barrett's esophagus	0.000348	0.00132	CcSEcCtD
Fluvoxamine—Constipation—Esomeprazole—Barrett's esophagus	0.000348	0.00132	CcSEcCtD
Fluvoxamine—Constipation—Omeprazole—Barrett's esophagus	0.000348	0.00132	CcSEcCtD
Fluvoxamine—CYP2E1—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000347	0.0141	CbGpPWpGaD
Fluvoxamine—CYP3A5—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000346	0.0141	CbGpPWpGaD
Fluvoxamine—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000335	0.00128	CcSEcCtD
Fluvoxamine—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000335	0.00128	CcSEcCtD
Fluvoxamine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000333	0.0135	CbGpPWpGaD
Fluvoxamine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000333	0.0135	CbGpPWpGaD
Fluvoxamine—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000333	0.00127	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000333	0.00127	CcSEcCtD
Fluvoxamine—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000331	0.0135	CbGpPWpGaD
Fluvoxamine—CYP1A1—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000327	0.0133	CbGpPWpGaD
Fluvoxamine—Urticaria—Omeprazole—Barrett's esophagus	0.000323	0.00123	CcSEcCtD
Fluvoxamine—Urticaria—Esomeprazole—Barrett's esophagus	0.000323	0.00123	CcSEcCtD
Fluvoxamine—CYP1A2—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000323	0.0131	CbGpPWpGaD
Fluvoxamine—Abdominal pain—Omeprazole—Barrett's esophagus	0.000322	0.00122	CcSEcCtD
Fluvoxamine—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000322	0.00122	CcSEcCtD
Fluvoxamine—Body temperature increased—Omeprazole—Barrett's esophagus	0.000322	0.00122	CcSEcCtD
Fluvoxamine—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000322	0.00122	CcSEcCtD
Fluvoxamine—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.0003	0.00114	CcSEcCtD
Fluvoxamine—Hypersensitivity—Omeprazole—Barrett's esophagus	0.0003	0.00114	CcSEcCtD
Fluvoxamine—Asthenia—Omeprazole—Barrett's esophagus	0.000292	0.00111	CcSEcCtD
Fluvoxamine—Asthenia—Esomeprazole—Barrett's esophagus	0.000292	0.00111	CcSEcCtD
Fluvoxamine—CYP2B6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000291	0.0118	CbGpPWpGaD
Fluvoxamine—Pruritus—Omeprazole—Barrett's esophagus	0.000288	0.0011	CcSEcCtD
Fluvoxamine—Pruritus—Esomeprazole—Barrett's esophagus	0.000288	0.0011	CcSEcCtD
Fluvoxamine—CYP2E1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000285	0.0116	CbGpPWpGaD
Fluvoxamine—CYP3A5—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000284	0.0116	CbGpPWpGaD
Fluvoxamine—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000278	0.00106	CcSEcCtD
Fluvoxamine—Diarrhoea—Omeprazole—Barrett's esophagus	0.000278	0.00106	CcSEcCtD
Fluvoxamine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000271	0.011	CbGpPWpGaD
Fluvoxamine—Dizziness—Esomeprazole—Barrett's esophagus	0.000269	0.00102	CcSEcCtD
Fluvoxamine—Dizziness—Omeprazole—Barrett's esophagus	0.000269	0.00102	CcSEcCtD
Fluvoxamine—CYP1A1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000269	0.0109	CbGpPWpGaD
Fluvoxamine—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000268	0.0109	CbGpPWpGaD
Fluvoxamine—CYP2C19—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000268	0.0109	CbGpPWpGaD
Fluvoxamine—Vomiting—Esomeprazole—Barrett's esophagus	0.000259	0.000985	CcSEcCtD
Fluvoxamine—Vomiting—Omeprazole—Barrett's esophagus	0.000259	0.000985	CcSEcCtD
Fluvoxamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000257	0.0104	CbGpPWpGaD
Fluvoxamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000257	0.0104	CbGpPWpGaD
Fluvoxamine—Rash—Omeprazole—Barrett's esophagus	0.000257	0.000977	CcSEcCtD
Fluvoxamine—Rash—Esomeprazole—Barrett's esophagus	0.000257	0.000977	CcSEcCtD
Fluvoxamine—Dermatitis—Omeprazole—Barrett's esophagus	0.000256	0.000976	CcSEcCtD
Fluvoxamine—Dermatitis—Esomeprazole—Barrett's esophagus	0.000256	0.000976	CcSEcCtD
Fluvoxamine—Headache—Omeprazole—Barrett's esophagus	0.000255	0.00097	CcSEcCtD
Fluvoxamine—Headache—Esomeprazole—Barrett's esophagus	0.000255	0.00097	CcSEcCtD
Fluvoxamine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000249	0.0101	CbGpPWpGaD
Fluvoxamine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000247	0.0101	CbGpPWpGaD
Fluvoxamine—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000246	0.01	CbGpPWpGaD
Fluvoxamine—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000244	0.00992	CbGpPWpGaD
Fluvoxamine—Nausea—Omeprazole—Barrett's esophagus	0.000242	0.00092	CcSEcCtD
Fluvoxamine—Nausea—Esomeprazole—Barrett's esophagus	0.000242	0.00092	CcSEcCtD
Fluvoxamine—CYP2C19—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00022	0.00894	CbGpPWpGaD
Fluvoxamine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000211	0.00859	CbGpPWpGaD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.00021	0.00852	CbGpPWpGaD
Fluvoxamine—CYP3A7—Biological oxidations—CYP26A1—Barrett's esophagus	0.000209	0.00849	CbGpPWpGaD
Fluvoxamine—CYP1A2—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000209	0.00848	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000206	0.00838	CbGpPWpGaD
Fluvoxamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000202	0.00822	CbGpPWpGaD
Fluvoxamine—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.0002	0.00815	CbGpPWpGaD
Fluvoxamine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000186	0.00756	CbGpPWpGaD
Fluvoxamine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000182	0.00741	CbGpPWpGaD
Fluvoxamine—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000178	0.00724	CbGpPWpGaD
Fluvoxamine—CYP1A2—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000171	0.00696	CbGpPWpGaD
Fluvoxamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000163	0.00663	CbGpPWpGaD
Fluvoxamine—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000161	0.00654	CbGpPWpGaD
Fluvoxamine—SLC6A4—NRF2 pathway—HGF—Barrett's esophagus	0.000158	0.0064	CbGpPWpGaD
Fluvoxamine—CYP2B6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000155	0.00628	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000152	0.0062	CbGpPWpGaD
Fluvoxamine—CYP2E1—Biological oxidations—CYP26A1—Barrett's esophagus	0.000151	0.00615	CbGpPWpGaD
Fluvoxamine—CYP3A5—Biological oxidations—CYP26A1—Barrett's esophagus	0.000151	0.00614	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000149	0.00607	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000149	0.00606	CbGpPWpGaD
Fluvoxamine—CYP1A1—Biological oxidations—CYP26A1—Barrett's esophagus	0.000143	0.0058	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000141	0.00572	CbGpPWpGaD
Fluvoxamine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000137	0.00558	CbGpPWpGaD
Fluvoxamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000132	0.00537	CbGpPWpGaD
Fluvoxamine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000128	0.00521	CbGpPWpGaD
Fluvoxamine—SLC6A3—NRF2 pathway—HGF—Barrett's esophagus	0.00012	0.00488	CbGpPWpGaD
Fluvoxamine—SLC6A3—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000119	0.00483	CbGpPWpGaD
Fluvoxamine—CYP2C19—Biological oxidations—CYP26A1—Barrett's esophagus	0.000117	0.00475	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000115	0.00468	CbGpPWpGaD
Fluvoxamine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.00011	0.00445	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000109	0.00444	CbGpPWpGaD
Fluvoxamine—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000107	0.00437	CbGpPWpGaD
Fluvoxamine—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	0.000106	0.00433	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.000106	0.00431	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000106	0.00431	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000105	0.00427	CbGpPWpGaD
Fluvoxamine—CYP1A1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	9.93e-05	0.00403	CbGpPWpGaD
Fluvoxamine—SLC6A3—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	9.85e-05	0.004	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—CYP26A1—Barrett's esophagus	9.1e-05	0.0037	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metapathway biotransformation—CYP26A1—Barrett's esophagus	8.98e-05	0.00365	CbGpPWpGaD
Fluvoxamine—SLC6A4—Circadian rythm related genes—PPARG—Barrett's esophagus	8.75e-05	0.00355	CbGpPWpGaD
Fluvoxamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	8.45e-05	0.00344	CbGpPWpGaD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	8.17e-05	0.00332	CbGpPWpGaD
Fluvoxamine—CYP2C19—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	8.12e-05	0.0033	CbGpPWpGaD
Fluvoxamine—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	7.41e-05	0.00301	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.23e-05	0.00294	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	7.02e-05	0.00285	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	6.96e-05	0.00283	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	6.93e-05	0.00282	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	6.77e-05	0.00275	CbGpPWpGaD
Fluvoxamine—CYP1A1—PPARA activates gene expression—PPARG—Barrett's esophagus	6.72e-05	0.00273	CbGpPWpGaD
Fluvoxamine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Barrett's esophagus	6.57e-05	0.00267	CbGpPWpGaD
Fluvoxamine—CYP1A2—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	6.33e-05	0.00257	CbGpPWpGaD
Fluvoxamine—SLC6A3—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	6.04e-05	0.00245	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	5.92e-05	0.00241	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	5.4e-05	0.00219	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	5.33e-05	0.00217	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	4.9e-05	0.00199	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PTGES—Barrett's esophagus	4.72e-05	0.00192	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	4.61e-05	0.00187	CbGpPWpGaD
Fluvoxamine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	4.53e-05	0.00184	CbGpPWpGaD
Fluvoxamine—SLC6A4—Circadian rythm related genes—TP53—Barrett's esophagus	4.09e-05	0.00166	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	3.57e-05	0.00145	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CYP26A1—Barrett's esophagus	3.57e-05	0.00145	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTGES—Barrett's esophagus	3.49e-05	0.00142	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTGES—Barrett's esophagus	3.42e-05	0.00139	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTGES—Barrett's esophagus	3.41e-05	0.00139	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTGES—Barrett's esophagus	3.22e-05	0.00131	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	3e-05	0.00122	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	2.71e-05	0.0011	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CYP26A1—Barrett's esophagus	2.64e-05	0.00107	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTGES—Barrett's esophagus	2.64e-05	0.00107	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CYP26A1—Barrett's esophagus	2.59e-05	0.00105	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	2.58e-05	0.00105	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—SLC9A1—Barrett's esophagus	2.58e-05	0.00105	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTGES—Barrett's esophagus	2.57e-05	0.00105	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CYP26A1—Barrett's esophagus	2.44e-05	0.000992	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTGES—Barrett's esophagus	2.42e-05	0.000985	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTGES—Barrett's esophagus	2.4e-05	0.000977	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTGES—Barrett's esophagus	2.05e-05	0.000835	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYP26A1—Barrett's esophagus	2e-05	0.000812	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	1.95e-05	0.000792	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—SLC9A1—Barrett's esophagus	1.91e-05	0.000774	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—SLC9A1—Barrett's esophagus	1.87e-05	0.000758	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	1.86e-05	0.000757	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	1.84e-05	0.000747	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	1.82e-05	0.00074	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.8e-05	0.000733	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—SLC9A1—Barrett's esophagus	1.76e-05	0.000715	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	1.62e-05	0.000656	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTGES—Barrett's esophagus	1.58e-05	0.000644	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP26A1—Barrett's esophagus	1.56e-05	0.000632	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.48e-05	0.0006	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—SLC9A1—Barrett's esophagus	1.44e-05	0.000585	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.42e-05	0.000577	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	1.41e-05	0.000571	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.35e-05	0.000547	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	1.32e-05	0.000538	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	1.31e-05	0.000534	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.2e-05	0.000488	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PPARG—Barrett's esophagus	1.18e-05	0.000478	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.16e-05	0.000472	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.15e-05	0.000467	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—SLC9A1—Barrett's esophagus	1.12e-05	0.000456	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.06e-05	0.00043	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PTGS2—Barrett's esophagus	9.25e-06	0.000376	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	9.05e-06	0.000368	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PPARG—Barrett's esophagus	8.7e-06	0.000353	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	8.66e-06	0.000352	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PPARG—Barrett's esophagus	8.52e-06	0.000346	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PPARG—Barrett's esophagus	8.5e-06	0.000345	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PPARG—Barrett's esophagus	8.03e-06	0.000326	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTGS2—Barrett's esophagus	6.84e-06	0.000278	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTGS2—Barrett's esophagus	6.7e-06	0.000272	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	6.69e-06	0.000272	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PPARG—Barrett's esophagus	6.57e-06	0.000267	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PPARG—Barrett's esophagus	6.41e-06	0.000261	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTGS2—Barrett's esophagus	6.32e-06	0.000257	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PPARG—Barrett's esophagus	6.04e-06	0.000246	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PPARG—Barrett's esophagus	5.99e-06	0.000244	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTGS2—Barrett's esophagus	5.17e-06	0.00021	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PPARG—Barrett's esophagus	5.12e-06	0.000208	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTGS2—Barrett's esophagus	5.05e-06	0.000205	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	4.76e-06	0.000193	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	4.71e-06	0.000192	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTGS2—Barrett's esophagus	4.03e-06	0.000164	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPARG—Barrett's esophagus	3.95e-06	0.000161	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	3.11e-06	0.000126	CbGpPWpGaD
